Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

BYD, dynaCERT, thyssenkrupp - Trump rollercoaster creates opportunities

The stock market currently resembles a rollercoaster, driven by US President Trump’s daily shifts in strategy regarding punitive tariffs. After suffering significant losses due to a historic crash earlier in the week, the losses turned into substantial gai...
Stefan Feulner | 4 days ago |

Tungsten shortage as a goldmine: Why Almonty Industries is becoming a key player for NATO countries

As early as the beginning of December 2024, there were initial indications that China would impose certain restrictions on its tungsten exports. After the Chinese government further tightened export control on tungsten and molybdenum in early February 2025, Western indust...
Armin Schulz | April 3, 2025 |

dynaCERT: 300% Potential with Cleantech! — GBC analysts vote “Buy”

Bernd Krüper, the new president and director since summer 2024, is looking hopefully toward the upcoming bauma trade fair in Munich. Energy efficiency and the climate transition are at the forefront of the public eye. Companies with high energy usage are actively seeking ...
Mario Hose | March 26, 2025 |

Buy recommendation for dynaCERT: GBC sees upside potential of over 300% to CAD 0.75!

Enter the green revolution: Cleantech stock with hydrogen potential! dynaCERT Inc. (ISIN: CA26780A1084 | TSX: DYA) is the focus of analyst Matthias Greiffenberger – and for good reason: The Canadian cleantech company is developing technologies to reduce emissions f...
Mario Hose | March 25, 2025 |

Buzz on the Bullboards: Breaking down the latest in tech, mining, and energy

Canada’s main stock index experienced a mixed week. On Monday, the index flatlined due to losses in the information technology and energy sectors, as investors remained cautious ahead of potential US tariffs. The telecom sector led gains on the TSX, while ...
Jonathon Brown | February 27, 2025 |

Revolution: dynaCERT on the way to becoming a unicorn

The stock market thrives on innovations and disruptive technologies. Companies that solve pressing problems and make their solutions scalable have the potential to deliver significant returns to their investors. dynaCERT (TSX:DYA) (WKN: A1KBAV | ISIN: CA26780A1084 | Tic...
Mario Hose | February 26, 2025 |

Buzz on the Bullboards: Despite tariffs, Bombardier flying high

Canada’s main stock index has been moving lower this week, as investors stepped away from big bets, driven by declines in energy, tech, and industrial companies. The index had already felt the weight of new potential U.S. tariffs on steel and aluminum...
Jonathon Brown | February 13, 2025 |

Buzz on the Bullboards: Trudeau quits, Trump gets (more) greedy

The past week has been eventful for the TSX , reflecting the broader economic and political landscape. Monday: Canada’s main stock index managed to maintain composure, registering a controlled loss following the unexpected resignation of Prime Minis...
Jonathon Brown | January 9, 2025 |

NervGen Pharma: Proof that NVG-291 works?

It’s arguably a Eureka moment for investors in NervGen Pharma (TSX.V: NGEN) (OTCQB: NGENF). Tantalizing anecdotal “evidence” has just been published that suggests that NervGen’s prospective wonder-drug — NVG-29...
Knox Henderson | December 23, 2024 |

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...
Research | December 11, 2024 |
1 2 3 4 5 6 7 8 9 10 ...